Syndrome of inappropriate antidiuretic hormone epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Syndrome of inappropriate antidiuretic hormone (SIADH) can occur at any age. Its [[incidence]] depends upon various possible [[etiologies]]. [[Prevalence]] of [[SIADH]] was estimated to be 2500-3000 cases per 100,000 individuals. The [[incidence]] and [[prevalence]] of [[SIADH]] in particular is less thoroughly studied in the literature. | Syndrome of inappropriate antidiuretic hormone (SIADH) can occur at any age. Its [[incidence]] depends upon various possible [[etiologies]]. [[Prevalence]] of [[SIADH]] was estimated to be 2500-3000 cases per 100,000 individuals. The [[incidence]] and [[prevalence]] of [[SIADH]] in particular is less thoroughly studied in the literature. Hospitalized patients with plasma [[sodium]] concentration <125 mmol/l show an overall mortality of 28000 per 100,000 patients. The [[incidence]] of [[SIADH]] increases with [[age]]. The [[prevalence]] and [[incidence]] of [[SIADH]] does not vary by gender. There is no racial predilection to [[SIADH]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 15:28, 8 August 2018
|
Syndrome of inappropriate antidiuretic hormone Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Syndrome of inappropriate antidiuretic hormone epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Syndrome of inappropriate antidiuretic hormone epidemiology and demographics |
|
FDA on Syndrome of inappropriate antidiuretic hormone epidemiology and demographics |
|
CDC on Syndrome of inappropriate antidiuretic hormone epidemiology and demographics |
|
Syndrome of inappropriate antidiuretic hormone epidemiology and demographics in the news |
|
Blogs on Syndrome of inappropriate antidiuretic hormone epidemiology and demographics |
|
Directions to Hospitals Treating Syndrome of inappropriate antidiuretic hormone |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Syndrome of inappropriate antidiuretic hormone (SIADH) can occur at any age. Its incidence depends upon various possible etiologies. Prevalence of SIADH was estimated to be 2500-3000 cases per 100,000 individuals. The incidence and prevalence of SIADH in particular is less thoroughly studied in the literature. Hospitalized patients with plasma sodium concentration <125 mmol/l show an overall mortality of 28000 per 100,000 patients. The incidence of SIADH increases with age. The prevalence and incidence of SIADH does not vary by gender. There is no racial predilection to SIADH.
Epidemiology and Demographics
Incidence
- SIADH is the most common cause of hyponatremia.[1]
- Incidence of moderate and severe hyponatraemia in the United States ranges from a low of 1000 to 7000 per 100,000 among hospitalized patients.[2]
Prevalence
- Prevalence of SIADH was estimated to be 2500-3000 cases per 100,000 individuals.
- Prevalence of hyponatremia in the United States has been estimated to be 1720 per 100,000 individuals.[3]
Mortality
- Hospitalized patients with plasma sodium concentration <125 mmol/l show an overall mortality of 28000 per 100,000 patients.[4]
Age
Gender
- The prevalence and incidence of SIADH does not vary by gender.
- The prevalence of hyponatremia is higher in females than males.[7]
Race
- There is no racial predilection to SIADH.
References
- ↑ O'Donoghue D, Trehan A (2009). "SIADH and hyponatraemia: foreword". NDT Plus. 2 (Suppl_3): iii1–iii4. doi:10.1093/ndtplus/sfp152. PMC 2762825. PMID 19881931.
- ↑ O'Donoghue D, Trehan A (2009). "SIADH and hyponatraemia: foreword". NDT Plus. 2 (Suppl_3): iii1–iii4. doi:10.1093/ndtplus/sfp152. PMC 2762825. PMID 19881931.
- ↑ Mohan S, Gu S, Parikh A, Radhakrishnan J (2013). "Prevalence of hyponatremia and association with mortality: results from NHANES". Am. J. Med. 126 (12): 1127–37.e1. doi:10.1016/j.amjmed.2013.07.021. PMC 3933395. PMID 24262726.
- ↑ Gill, Geoffrey; Huda, Bobby; Boyd, Alice; Skagen, Karolina; Wile, David; Watson, Ian; van Heyningen, Charles (2006). "Characteristics and mortality of severe hyponatraemia ? a hospital-based study". Clinical Endocrinology. 65 (2): 246–249. doi:10.1111/j.1365-2265.2006.02583.x. ISSN 0300-0664.
- ↑ Tarif N, Sabir O, Niaz A, Akhtar R, Rafique K, Rizvi N (2016). "Hyponatraemia: Epidemiology and aetiology in a tertiary care centre in Pakistan". J Pak Med Assoc. 66 (11): 1436–1439. PMID 27812063.
- ↑ Flear CT, Gill GV, Burn J (1981). "Hyponatraemia: mechanisms and management". Lancet. 2 (8236): 26–31. PMID 6113402.
- ↑ Lien YH, Shapiro JI (2007). "Hyponatremia: clinical diagnosis and management". Am. J. Med. 120 (8): 653–8. doi:10.1016/j.amjmed.2006.09.031. PMID 17679119.